NCT06505577 Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study
| NCT ID | NCT06505577 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Incheon St.Mary's Hospital |
| Condition | Mastectomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2024-08-01 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Breast cancer, the most prevalent malignancy among women globally, is increasing in incidence. While non-metastatic breast cancer requires surgery, determining the optimal extent of resection remains challenging. Inadequate resection margins necessitate reoperation, leading to increased psychological stress, costs, and potentially compromised cosmetic outcomes and prognosis. Accurate preoperative assessment of resection extent is crucial and involves various factors, including imaging studies, physical examinations, tumor molecular subtypes, and intraductal carcinoma components. This prospective observational study aims to identify and integrate multiple predictive factors to enhance surgical planning and minimize reoperation rates in breast cancer patients.
Eligibility Criteria
Inclusion Criteria: Adult patients (≥ 19 years old) diagnosed with breast cancer (invasive and in situ). Patients scheduled for surgical resection of the tumor Availability of both preoperative tumor size assessments and pathologic measurements post-surgery Exclusion Criteria: Patients with recurrent breast cancer Inflammatory breast cancer Patients who did not undergo surgery Patients whose preoperative tumor size data is not available or deficient for analyzing
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06505577 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Mastectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06505577 currently recruiting?
Yes, NCT06505577 is actively recruiting participants. Contact the research team at yjkang.md@gmail.com for enrollment information.
Where is the NCT06505577 trial being conducted?
This trial is being conducted at Incheon, South Korea.
Who is sponsoring the NCT06505577 clinical trial?
NCT06505577 is sponsored by Incheon St.Mary's Hospital. The trial plans to enroll 600 participants.